Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

NCT00087126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

DRUG: topotecan hydrochloride

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]